Toward affordable cancer drugs: Do we need firmer price negotiation, me-too drugs, or a biosimilar silver bullet?

Semin Oncol

Division of Cancer Care and Epidemiology, Queen's University Cancer Research Institute, Kingston, Canada; Department of Oncology,(, ) Queen's University, Kingston, Canada. Electronic address:

Published: December 2020

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2020.10.001DOI Listing

Publication Analysis

Top Keywords

affordable cancer
4
cancer drugs
4
drugs firmer
4
firmer price
4
price negotiation
4
negotiation me-too
4
me-too drugs
4
drugs biosimilar
4
biosimilar silver
4
silver bullet?
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!